PRW Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

PRW Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,467	Closed	-$232K	–	118
2021 Q2	$232K	Buy	+3,467	New	+$226K	0.07%	239
2019 Q2	–	Sell	-881	Closed	-$42K	–	136
2019 Q1	$42K	Sell	881 -82	-9%	-$4.08K	0.04%	159
2018 Q4	$50K	Buy	+963	New	+$51.7K	0.06%	133

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PRW Wealth Management's BMY Position: Q3 2021 in Review

PRW Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 3,467 shares — an estimated $232K sold.

PRW Wealth Management first reported a position in BMY in Q4 2018 and held it in 3 quarters. The position peaked at $232K in Q2 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

PRW Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
PRW Wealth Management sold 3,467 Bristol-Myers Squibb shares in Q3 2021, an estimated $232K.
PRW Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 3 quarters.
PRW Wealth Management's Bristol-Myers Squibb position peaked at $232K in Q2 2021.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on PRW Wealth Management's 13F filing for Q3 2021, filed 4 Nov 2021.